
Maximus and United Natural Foods - Worth Taking a Look
Episode notes
Today is Friday, September 11th 2026. Macro events dominated this week with the price of Diesel climbing over $6 per gallon, and the US 10-year bond approaching 5%.
What Worked in Value:
Frank Value Fund just filed its annual report and holdings as of June 30, 2026. We disclosed positions in healthcare companies Icon Plc and Becton Dickinson, as well as defense contractors Maximus, Science Applications International, and Leidos Holdings.
Maximus is a compelling idea. The company market cap is around $3 billion and they produce nearly $500 million of free cash flow annually. That is nearly 15% of the company value hitting the balance sheet every year. It won't take long for this cash to materially reduce shares outstanding as repurchases, enrich shareholders as dividends, or reduce the debt significantly.
What didn't work?
However, even at $45 this week, UNFI is extremely under-valued. The company has a 10% FCF/Mcap yield, announced a $200 million repurchase which is around 7% of shares outstanding, and has a better balance sheet than its publicly traded peers.
Next up is On the Hunting Trail for Value
As I mentioned last week and in the previous segment, consumer staples are once again the target of the market's disrespect. I added another staples company to my portfolio this week, and it is not only trading at a low valuation, but it also has the ability to grow EBITDA, or pre-tax cash flow, at a low double digit rate.
Wrapping Up:
The macro is making things a lot more difficult but we have yet to see fear show up in the stock market indices. Value investing in healthcare and defense contractors has so far paid off well in 2026, and consumer staples continue to lead the way in compelling opportunities looking forward. Thanks for listening and have a great weekend.
Website: https://frankfunds.com
Brian X Account: https://x.com/bfrankvalue
Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. You may obtain performance data current to the most recent month-end by calling the Fund at 1-888-217-5426 or visiting our website at www.frankfunds.com. Returns include reinvestment of any dividends and capital gain distributions.
Non-FDIC insured. May lose value. No bank guarantee. The Fund's investment objectives, risks, charges and expenses must be considered carefully before investing. The prospectus contains this and other important information about the Fund, and it may be obtained by calling 1-888-217-5426. Please read it carefully before you invest or send money.
This publication does not constitute an offer or solicitation of any transaction in any securities. Any recommendation contained herein may not be suitable for all investors. Information contained in this publication has been obtained from sources we believe to be reliable, but cannot be guaranteed.
The information in this portfolio manager letter represents the opinions of the individual portfolio managers and is not intended to be a forecast of future events, a guarantee of future results or investment advice. Also, please note that any discussion of the Fund's holdings, the Fund's performance, and the portfolio managers' views are as of the date of this recording and are subject to change without notice.